Skip to main content


Conferences

Clinical Pathways Congress 2018

October 28, 2018

October 26-28 marks the third annual Clinical Pathways Congress. Leading experts convene in Boston, MA to dive in and address the operational questions raised by cancer center directors, clinical pathways directors, medical and pharmacy benefit managers, pathway vendors, and other stakeholders involved on pathway committees about design, development, implementation, utilization, and outcome measurement.


How Do We Measure ROI for Clinical Pathways?

Ray D Page, DO, PhD, explained how pathways can serve as a mechanism to pressure drug pricing, assist in prior authorization burden, and provide system-wide cost savings.

Read More

 

Updates to the OCM Quality Measures and Lessons Learned Moving Forward

Andrew York, PharmD, JD, of CMMI, provided and update on the role of quality improvement in oncology value-based payment, with specific attention to OCM Quality Measures.

Read More

 

Challenges in Personalization, Integration of Pathways

Linda Bosserman, MD, FASCO, FACP, explains the importance of using decision support platforms that integrate care pathways and make use of collected data in real time to promote evidence-based patient care.

Read More

 

Incorporating Patient Experience, Financial Toxicity Into Clinical Pathways

Alan Balch, PhD, chief executive officer, National Patient Advocate Foundation, discussed the need to consider clinical pathways in helping differentiate options based on financial and logistical side effects that impact the patients’ care journey.

Read More

 

Pros and Cons of Vendor- and Provider-Developed Pathways

Bobby Daly, MD, MBA, and Robin Zon, MD, FACP, FASCO, outline the key elements for practices to consider in determining whether to buy or build their own pathways.

Read More

 

The Current State of Clinical Pathways: Results From the Inaugural Benchmarking Survey

Winston Wong, PharmD, explained the findings of the first JCP clinical pathways benchmarking survey, including  respondents’ reasons for pathway implementation, barriers to implementation, and potential for clinical pathways outside of oncology.

Read More

 

Clinical Pathways Congress 2018 Preview

Listen to Winston Wong, PharmD, summarize the key sessions and topics on the agenda at the 2018 Clinical Pathways Congress this October in Boston, MA.

Read More

 

ASCO Endorses Clinical Pathways Congress

JCP is the official journal of the Clinical Pathways Congress meeting.

Read More

Back to Top